|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Confidence in linear spectral unmixing of single pixels显示文摘 | Petrou Maria Foschi Patricia G | 1999 | IEEE Transactions on Geoscience and Remote Sensing1999，37，1： | 1 |
| 2 | Influence of mortar rheology on aggregates settlement 显示文摘 | PETROU M F WAN B GADALA - MARIA F | 2000 | ACI Materials Journal2000，97，4： | 1 |
| 3 | Multidimensional Co-occurrence Matrices for Object Rrecognition and Matching显示文摘 | Kovalev Vassili Petrou Maria | 1996 | Graphical Models and Image Processing1996，58，3： | 1 |
| 4 | Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents显示文摘AIM To evaluate the outcomes in biological treatment and quality of life of psoriatic patients with chronic hepatitis C(CHC) treated with new Direct-Acting Antiviral agents(DAAs) compared to pegylated interferon-2α plus ribavirin(P/R) therapy.METHODS This is a retrospective study involving psoriatic patients in biological therapy who underwent anti-hepatitis C virus(HCV) treatment at the Department of Dermatology Galeazzi Orthopaedic Institute Milan, Italy from January 2010 to November 2017. The patients were divided into two groups: patients that underwent therapy with DAAs and patients that underwent HCV treatment with P/R. Patients were assessed by a dermatologist for psoriasis symptoms, collecting Psoriasis Area Severity Index(PASI) scores and the Dermatology Quality of Life Index(DLQI). PASI and DLQI scores were evaluated 24 wk after the end of HCV treatment and were assumed as an outcome of the progression of psoriasis. Switching to a different b DMARD was considered as an inadequate response to biological therapy. The dropout of HCV therapy and sustained virological response(SVR) were considered as outcomes of HCV therapy.RESULTS Fifty-nine psoriatic patients in biological therapy underwent antiviral therapy for CHC. Of this, 27 patients were treated with DAAs and 32 with P/R. After 24 wk post treatment, the DLQI and the PASI scores were significantly lower(P < 0.001 and P < 0.005, respectively) in the DAAs group compared with P/R group. None of the patients in the DAAs group(0/27) compared to 8 patients of the P/R group(8/32) needed a shift in biological treatment.CONCLUSION DAAs seem to be more effective and safe than P/R in HCV-positive psoriatic patients on biological treatment. Fewer dermatological adverse events may be due to interferon-free therapy. | Giovanni Damiani Chiara Franchi Paolo Pigatto Andrea Altomare Alessia Pacifico Stephen Petrou Sebastiano Leone Maria Caterina Pace Marco Fiore | 2018 | World Journal of Hepatology2018，10，2： | 1 |
| 5 | The trace transform and its application 显示文摘 | Alexander Kadyrov Maria Petrou | 2005 | IEEE Transactions on Pattern Analysis and Machine Intelligence2005，23，8： | 1 |
| 6 | A unique experimental method for monitoring aggre- gate settlement in concrete 显示文摘 | PETROU M F HARRIES K A GADALA - MARIA F Venkata Girl Kolli | 2000 | Cement and Concrete Research2000，，30： | 1 |
| 7 | On the choice of the parameters for anisotropic diffusion in image processing显示文摘 | Chourmouzios Tsiotsios Maria Petrou | 2012 | Pattern Recognition2012，，： | 1 |
| 8 | The 4-Source photometric stereo technique for three-dimensional surfaces in the presence of highlights and shadows显示文摘 | Svetlana Barsky Maria Petrou | 2003 | IEEE Trans on PAMI2003，25，10： | 1 |
| 9 | Spontaneous bacterial peritonitis due to carbapenemase-producing Enterobacteriaceae:Etiology and antibiotic treatment显示文摘Carbapenem antibiotics were first introduced in the 1980s and have long been considered the most active agents for the treatment of multidrug-resistant gramnegative bacteria.Over the last decade,carbapenem-resistant Enterobacteriaceae(CRE)have emerged as organisms causing spontaneous bacterial peritonitis.Infections caused by CRE have shown a higher mortality rate than those caused by bacteria sensitive to carbapenem antibiotics.Current antibiotic guidelines for the treatment of spontaneous bacterial peritonitis are insufficient,and rapid deescalation of empiric antibiotic treatment is not widely recognized.This review summarizes the molecular characteristics,epidemiology and possible treatment of spontaneous bacterial peritonitis caused by CRE. | Marco Fiore Sveva Di Franco Aniello Alfieri Maria Beatrice Passavanti Maria Caterina Pace Stephen Petrou Francesca Martora Sebastiano Leone | 2020 | World Journal of Hepatology2020，12，12： | 1 |
| 10 | On the Choice of the Parameters for a Nisotropic Diffusion in Image Processing显示文摘 | Tsiotsios Chourmouzios Petrou Maria | 2012 | Pattern Reconintion2012，46，5： | 1 |
| 11 | The trace transform and its applications显示文摘 | Alexander Kadyrov Maria Petrou | 2001 | IEEE Transactions on Pattern Analysis and Machine Intelligence2001，23，8： | 1 |
| 12 | Multidimensional co-occurrence matrices for object recognition and matching显示文摘 | Kovalev Vassili Petrou Maria | 1996 | Graphical Models and Image Processing1996，58，3： | 1 |
| 13 | Automatic registration of ceramic tiles for the purpose of fault detection 显示文摘 | Cristina E Costa Maria Petrou | 2000 | Machine Vision and Applications2000，，11： | 1 |
| 14 | Reconstruction of 3-D Horizons From 3-D Seismic Datasets 显示文摘 | Alexander Blinov and Maria Petrou | 2005 | IEEE transactions on geoscience and remote sensing2005，43，6： | 1 |
| 15 | Reconstruction of 3-D Horizons From 3-D Seismic Datasets显示文摘 | Alexander Blinov and Maria Petrou | 2005 | IEEE transactions on geoscience and remote sensing2005，43，6： | 1 |
| 16 | 根据形状类型信息由图像中的明暗变化获取物体的表面方向显示文摘研究一种专门用于 SFS(由图像的明暗重构物体表面三维形状 )结合其它辅助信息的条件下 ,提取光滑物体表面方向信息的 SFS算法。物体表面上的曲面片按其方向曲率的符号组合分成 4种类型 :凸形、凹形、横向鞍形和纵向鞍形 ,以便于利用辅助信息加以实际判别。对应于这种分类方式 ,设计出相应的 4种由明暗关系计算表面方向的算法基本算子。这种新算法在算子与表面类型相匹配的情况下 ,能够取得很好的结果。 | 须明 赵荣椿 Maria Petrou | 2005 | 西北工业大学学报2005，23，1： | 0 |
| 17 | Medicinal cannabis products for the treatment of acute pain显示文摘For thousands of years,medicinal cannabis has been used for pain treatment,but its use for pain management is still controversial.Meta-analysis of the literature has shown contrasting results on the addition of cannabinoids to opioids compared with placebo/other active agents to reduce pain.Clinical studies are mainly focused on medicinal cannabis use in chronic pain management,for which the analgesic effect has been proven in many studies.This review focuses on the potential use of medical cannabis for acute pain management in preclinical studies,studies on healthy subjects and the few pioneering studies in the clinical setting. | Marco Fiore Aniello Alfieri Sveva Di Franco Stephen Petrou Giovanni Damiani Maria Caterina Pace | 2023 | World Journal of Clinical Cases2023，11，12： | 0 |
| 18 | Antimicrobial approach of abdominal post-surgical infections显示文摘Abdominal surgical site infections(SSIs)are infections that occur after abdominal surgery.They can be superficial,involving the skin tissue only,or more profound,involving deeper skin tissues including organs and implanted materials.Currently,SSIs are large global health problem with an incidence that varies significantly depending on the United Nations’Human Development Index.The purpose of this review is to provide a practical update on the latest available literature on SSIs,focusing on causative pathogens and treatment with an overview of the ongoing studies of new therapeutic strategies. | Marco Fiore Antonio Corrente Sveva Di Franco Aniello Alfieri Maria Caterina Pace Francesca Martora Stephen Petrou Claudio Mauriello Sebastiano Leone | 2023 | World Journal of Gastrointestinal Surgery2023，15，12： | 0 |
| 19 | Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit显示文摘Intensive care units(ICU)for various reasons,including the increasing age of admitted patients,comorbidities,and increasingly complex surgical procedures(e.g.,transplants),have become'the epicenter'of nosocomial infections,these are characterized by the presence of multidrug-resistant organisms(MDROs)as the cause of infection.Therefore,the perfect match of fragile patients and MDROs,as the cause of infection,makes ICU mortality very high.Furthermore,carbapenems were considered for years as last-resort antibiotics for the treatment of infections caused by MDROs;unfortunately,nowadays carbapenem resistance,mainly among Gram-negative pathogens,is a matter of the highest concern for worldwide public health.This comprehensive review aims to outline the problem from the intensivist's perspective,focusing on the new definition and epidemiology of the most common carbapenem-resistant MDROs(Acinetobacter baumannii,Pseudomonas aeruginosa and Enterobacterales)to emphasize the importance of the problem that must be permeating clinicians dealing with these diseases. | Maria Caterina Pace Antonio Corrente Maria Beatrice Passavanti Pasquale Sansone Stephen Petrou Sebastiano Leone Marco Fiore | 2023 | World Journal of Clinical Cases2023，11，13： | 0 |
| 20 | Current status of COVID-19 treatment:An opinion review显示文摘The pandemic severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection has garnered the attention of scientists worldwide in the search for an effective treatment while also focusing on vaccine development.Several drugs have been used for the management of coronavirus disease 2019(COVID-19),which has affected many hospitals and health centers worldwide.Statistically significant results are lacking on the effectiveness of the experimented drugs in reducing COVID-19 morbidity or mortality,as there are very few published randomized clinical trials.Despite this,the literature offers some material for study and reflection.This opinion review attempts to address three burning questions on COVID-19 treatment options.(1)What kind of studies are currently published or ongoing in the treatment of patients with COVID-19?(2)What drugs are currently described in the literature as options of treatment for patients affected by the infection?And(3)Are there specific clinical manifestations related to COVID-19 that can be treated with a customized and targeted therapy?By answering these questions,we wish to create a summary of current COVID-19 treatments and the anti-COVID-19 treatments proposed in the recent clinical trials developed in the last 3 mo,and to describe examples of clinical manifestations of the SARS-CoV-2 infection with a cause-related treatment. | Sveva Di Franco Aniello Alfieri Stephen Petrou Giovanni Damiani Maria Beatrice Passavanti Maria Caterina Pace Sebastiano Leone Marco Fiore | 2020 | World Journal of Virology2020，9，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员